Pugliese MT - Search Results

1

Strategies for Implementing Occupational eMental Health Interventions: Scoping Review.

Bernard RM, Toppo C, Raggi A, de Mul M, de Miquel C, Pugliese MT, van der Feltz-Cornelis CM, Ortiz-Tallo A, Salvador-Carulla L, Lukersmith S, Hakkaart-van Roijen L, Merecz-Kot D, Staszewska K, Sabariego C. Bernard RM, et al. Among authors: pugliese mt. J Med Internet Res. 2022 Jun 1;24(6):e34479. doi: 10.2196/34479. J Med Internet Res. 2022. PMID: 35648457 Free PMC article. Review.

2

Histone deacetylase inhibition affects sodium iodide symporter expression and induces 131I cytotoxicity in anaplastic thyroid cancer cells.

Pugliese M, Fortunati N, Germano A, Asioli S, Marano F, Palestini N, Frairia R, Boccuzzi G, Catalano MG. Pugliese M, et al. Thyroid. 2013 Jul;23(7):838-46. doi: 10.1089/thy.2012.0359. Thyroid. 2013. PMID: 23531031 Free article.

3

High energy shock waves activate 5'-aminolevulinic Acid and increase permeability to Paclitaxel: antitumor effects of a new combined treatment on anaplastic thyroid cancer cells.

Catalano MG, Costantino L, Fortunati N, Bosco O, Pugliese M, Boccuzzi G, Berta L, Frairia R. Catalano MG, et al. Thyroid. 2007 Feb;17(2):91-9. doi: 10.1089/thy.2006.0142. Thyroid. 2007. PMID: 17316109

4

The pan-DAC inhibitor LBH589 is a multi-functional agent in breast cancer cells: cytotoxic drug and inducer of sodium-iodide symporter (NIS).

Fortunati N, Catalano MG, Marano F, Mugoni V, Pugliese M, Bosco O, Mainini F, Boccuzzi G. Fortunati N, et al. Breast Cancer Res Treat. 2010 Dec;124(3):667-75. doi: 10.1007/s10549-010-0789-z. Epub 2010 Mar 9. Breast Cancer Res Treat. 2010. PMID: 20213084

5

Valproic acid, a histone deacetylase inhibitor, enhances sensitivity to doxorubicin in anaplastic thyroid cancer cells.

Catalano MG, Fortunati N, Pugliese M, Poli R, Bosco O, Mastrocola R, Aragno M, Boccuzzi G. Catalano MG, et al. J Endocrinol. 2006 Nov;191(2):465-72. doi: 10.1677/joe.1.06970. J Endocrinol. 2006. PMID: 17088416

6

Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell lines.

Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G. Catalano MG, et al. Endocr Relat Cancer. 2007 Sep;14(3):839-45. doi: 10.1677/ERC-07-0096. Endocr Relat Cancer. 2007. PMID: 17914112

7

Effects of the histone deacetylase inhibitor valproic acid on the sensitivity of anaplastic thyroid cancer cell lines to imatinib.

Catalano MG, Pugliese M, Poli R, Bosco O, Bertieri R, Fortunati N, Boccuzzi G. Catalano MG, et al. Oncol Rep. 2009 Feb;21(2):515-21. Oncol Rep. 2009. PMID: 19148530

8

Emerging molecular therapies of advanced thyroid cancer.

Catalano MG, Poli R, Pugliese M, Fortunati N, Boccuzzi G. Catalano MG, et al. Mol Aspects Med. 2010 Apr;31(2):215-26. doi: 10.1016/j.mam.2010.02.006. Epub 2010 Feb 20. Mol Aspects Med. 2010. PMID: 20176050 Review.

9

Cytotoxic activity of the histone deacetylase inhibitor panobinostat (LBH589) in anaplastic thyroid cancer in vitro and in vivo.

Catalano MG, Pugliese M, Gargantini E, Grange C, Bussolati B, Asioli S, Bosco O, Poli R, Compagnone A, Bandino A, Mainini F, Fortunati N, Boccuzzi G. Catalano MG, et al. Int J Cancer. 2012 Feb 1;130(3):694-704. doi: 10.1002/ijc.26057. Epub 2011 May 5. Int J Cancer. 2012. PMID: 21400508 Free article.

10

Histone deacetylase inhibition modulates E-cadherin expression and suppresses migration and invasion of anaplastic thyroid cancer cells.

Catalano MG, Fortunati N, Pugliese M, Marano F, Ortoleva L, Poli R, Asioli S, Bandino A, Palestini N, Grange C, Bussolati B, Boccuzzi G. Catalano MG, et al. J Clin Endocrinol Metab. 2012 Jul;97(7):E1150-9. doi: 10.1210/jc.2011-2970. Epub 2012 May 4. J Clin Endocrinol Metab. 2012. PMID: 22563106

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page